ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026

Rhea-AI Summary

ALX Oncology (Nasdaq: ALXO) announced participation in three investor events in Q1 2026: Wells Fargo Executive Biotech Summit (one-on-one meetings, Feb 24-25, 2026, Lake Tahoe, CA), TD Cowen 46th Annual Health Care Conference (presentation, Mar 3, 2026, 9:10 AM EST, Boston, MA; webcast available), and UBS Biotech Summit (one-on-one meetings, Mar 10, 2026, Miami, FL).

The TD Cowen webcast will be accessible via the Investors section at www.alxoncology.com and replayed for up to 90 days.

Market Reaction

-4.49% $2.48

15m delay 22 alerts

-4.49% Since News

$2.48 Last Price

$2.20 $2.66 Day Range

-$16M Valuation Impact

$341M Market Cap

2K Volume

Following this news, ALXO has declined 4.49%, reflecting a moderate negative market reaction. Our momentum scanner has triggered 22 alerts so far, indicating elevated trading interest and price volatility. The stock is currently trading at $2.48. This price movement has removed approximately $16M from the company's valuation.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.

SOUTH SAN FRANCISCO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology”; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in the Wells Fargo Executive Biotech Summit, TD Cowen 46th Annual Health Care Conference, and UBS Biotech Summit.

The details of the meetings are as follows:

Wells Fargo Executive Biotech Summit

Format: One-on-one meetings
Date: February 24-25, 2026
Location: Lake Tahoe, CA

TD Cowen 46th Annual Health Care Conference

Format: Presentation
Date: March 3, 2026
Time: 9:10 AM EST
Location: Boston, MA
Webcast link: Available here

UBS Biotech Summit

Format: One-on-one meetings
Date: March 10, 2026
Location: Miami, FL

The webcast of the TD Cowen 46th Annual Health Care Conference presentation can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com under the Events section of the Events and Presentations tab. Replay of the webcast will be archived for up to 90 days following the presentation date.

About ALX Oncology
ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. ALX Oncology’s second pipeline candidate, ALX2004, is a novel EGFR-targeted antibody-drug conjugate with a differentiated mechanism of action. A Phase 1 dose-escalation trial of ALX2004 is ongoing in patients with EGFR-expressing solid tumors. More information is available at www.alxoncology.com and on LinkedIn @ALX Oncology.

Investor Relations Contact:
Elhan Webb, CFA, IR Consultant
ewebb@alxoncology.com

Media Contact:
Michele Parisi, SparkPoint Healthcare Communications
mparisi@sparkpointpr.com 
(925) 864-5028

FAQ

When will ALX Oncology (ALXO) present at the TD Cowen 46th Annual Health Care Conference?

ALX Oncology will present on March 3, 2026 at 9:10 AM EST during the TD Cowen 46th Annual Health Care Conference in Boston. According to the company, the presentation will be webcast and the replay archived for up to 90 days on its Investors Events page.

How can investors watch ALX Oncology's (ALXO) TD Cowen presentation webcast?

Investors can access the webcast via the Investors section of ALX Oncology's website under Events and Presentations. According to the company, the live webcast link is posted on www.alxoncology.com and a replay will be available for up to 90 days following the presentation.

What are the dates and formats for ALX Oncology (ALXO) meetings at Q1 2026 conferences?

ALX Oncology will hold one-on-one meetings at Wells Fargo on Feb 24-25, 2026 and at UBS on Mar 10, 2026, and a presentation at TD Cowen on Mar 3, 2026. According to the company, locations are Lake Tahoe, Boston, and Miami respectively.

Will ALX Oncology (ALXO) provide a replay of its TD Cowen conference presentation?

Yes. According to the company, a replay of the TD Cowen presentation will be archived for up to 90 days. Investors can find the replay in the Events and Presentations section of the Investors page at www.alxoncology.com.

Where will ALX Oncology (ALXO) hold one-on-one meetings during Q1 2026 investor events?

ALX Oncology scheduled one-on-one meetings at the Wells Fargo Executive Biotech Summit in Lake Tahoe on Feb 24-25, 2026 and at the UBS Biotech Summit in Miami on Mar 10, 2026. According to the company, these are in-person investor meetings.